Loading clinical trials...
Loading clinical trials...
Comparaison d'Une Nouvelle Technique de Mesure de l'insulinorésistance Par Scintigraphie Avec la Technique de référence : Utilisation du 6-DIG Comme Marqueur du Transport du Glucose.
Conditions
Interventions
6-DIG
clamp
Locations
1
France
Hôpital Michallon . CHU Grenoble
Grenoble, France
Start Date
May 13, 2014
Primary Completion Date
March 1, 2018
Completion Date
March 1, 2018
Last Updated
August 26, 2021
NCT00001987
NCT07051005
NCT07483723
NCT07480161
NCT04786262
NCT06748963
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions